News

Data highlights novel PARP1 and ATR inhibitors with progress toward next-generation therapies for hard-to-treat malignancies VANCOUVER, British Columbia, April 29, 2025 (GLOBE NEWSWIRE) -- Rakovina ...
Free ChatGPT users can now access a lightweight version of OpenAI's Deep Research tool powered by a cost effective o4-mini ...